BrightOwl Loader Loading

Summary

Over 25 years in sales and marketing across different therapeutic areas and markets. niche areas (including orphan therapies), sales & marketing, company start-up, new markets & therapeutic areas introduction, negotiation & management of commercial partnerships and distribution agreements.

Experiences

Current Experience

  • Chief Commercial Officer
    Since February 2015
    CCO EU and RoW. Santhera has a late-stage development pipeline in orphan indications. The lead compound Raxone®/Catena® (INN: idebenone) is being developed in three indications: Leber's Hereditary Optic Neuropathy (LHON), Duchenne Muscular Dystrophy (DMD), and Primary Progressive Multiple Sclerosis (PPMS). More about it on www.santhera.com.

Past Experience

  • Senior Vice President, Mid-Sized Countries
    November 2011 --- January 2015
    Senior Vice President MidSize Countries in EU managing the 3 existing clusters and an interesting expansion project both in EU and outside. 50% of working time spent across the managed countries, with a team of 30 employees. Interim Country Manager Italy between Nov. 2012 - Mar. 2013. InterMune got acquired by Roche in the summer of 2014.

  • Senior Vice President, New Markets
    June 2010 --- November 2011
    Senior VP in the New Market region, reporting directly into Eisai WW HQ in Tokyo, Japan. Entry projects in Russia and Turkey.

  • Regional Director
    April 2009 --- June 2010
    P&L Mid-size affiliates responsability in EU, existing distributors management and current expansion projects in enlarged EU, including CIS and Mediterranean area.

  • Managing Director Italy
    March 2005 --- March 2009
    Start-up of the company (Italian affiliate of the Japanese multinational) during spring '05. Office based in San Donato Milanese (Milan, Italy). Affiliate profitable from 1st year with 70 full time employees. 3 successful price negotiations in 2 years.

  • General Manager Italy
    January 2003 --- January 2005
    P&L responsability for the Italian branch of the Danish multinational, world leader in allergy vaccine therapy. Regained market leadership during my tenure and rebuilt an efficient professional network in the field of allergy.

  • Business Unit Director Italy
    January 2001 --- January 2003
    Retail business unit marketing also specialist products to selected targets.

  • Various positions in sales and marketing
    January 1988 --- January 2001
    Intl. Mktg and sales in US, Antinfective Mktg. Dir. Europe, Oncology Dir. in Spain, Retail Sales Manager in Italy

Knowledge

LinkedIn Assessment :
PharmaceuticalsoncologyTherapeutic AreasOrphan DrugsVaccinesPharmaceutical salesPharmaceutical IndustryBiotechnologyMarket accessTherapeutic AreasNeurologyOrphan DrugsSales EffectivenessStart-upsmanagementLeadershipProduct launchBiopharmaceuticalsHospital SalesLife SciencesStart-up

Education

  • Veterinary medicine in from Universita' degli Studi di Sassari in 1986
  • Licenza liceale in from Liceo Classico D.A. Azuni in 1978

Area / Region

Liestal, Switzerland

Others

Driving License
  • Yes